Form 8-K - Current report:
SEC Accession No. 0001564590-21-043064
Filing Date
2021-08-10
Accepted
2021-08-10 16:01:56
Documents
14
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-8k_20210810.htm   iXBRL 8-K 32943
2 EX-99.1 bdsx-ex991_6.htm EX-99.1 330367
3 GRAPHIC gwssiei3daem000001.jpg GRAPHIC 2857
  Complete submission text file 0001564590-21-043064.txt   516036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20210810.xsd EX-101.SCH 5760
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20210810_lab.xml EX-101.LAB 20218
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20210810_pre.xml EX-101.PRE 12072
7 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-8k_20210810_htm.xml XML 3686
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 211159813
SIC: 8071 Services-Medical Laboratories